Stories. Questions. Different perspectives.
Browse WAURE
← Advice & Questions
Health · Advice & Questions ·

I no longer feel palpitations. What should I ask before assuming my AF anticoagulant has done its job?

Health category photographHealth

At my next atrial fibrillation review I want to ask a question I have been avoiding: if I cannot feel the fluttering now, why am I still taking the anticoagulant? I keep calling all my tablets “heart medicine”, which is probably why I have muddled together what each one is meant to do.

The NHS explanation of AF treatment distinguishes medicines for heart rate or rhythm from anticoagulants used to lower clot or stroke risk. It also says AF can occur without symptoms. I am following my prescription while I ask about my own plan, rather than using how my pulse feels to decide whether to skip it.

How can I get a useful explanation of the benefit, risks and review plan without leaving with only “keep taking it”? I want to understand the decision well enough to participate in it.

Discussion

5 community replies

Bring the names of the medicines and ask what each one is intended to do. You have already spotted that one broad label is hiding different purposes; a short explanation beside each name could make the whole plan easier to follow.

Put your question at the start of the review. “I have continued taking it, but I do not understand how the decision is made when I feel well” is useful information for the clinician, not a confession of being difficult.

Ask what factors in your own history informed the anticoagulant decision, what problems you should report and when the balance will be reviewed. A discussion of your circumstances is more useful than trying to borrow someone else's risk calculation.

A written plan could help, but would it answer the part you are most worried about? If the real concern is bleeding or another possible harm, name that rather than hoping a general explanation will eventually reach it.

Agreed. The purpose of the medicine and a worry about its risks can both be discussed. Ask the team to explain the benefits and harms together, and who to contact with concerns between reviews, instead of treating understanding the purpose as the end of the conversation.

Join the discussion

More in Health